speb/financial-data huggingface dataset:
Financial ratios for EICHERMOT.NS — quarterly report dated 2025-03-31
Total revenue: 602101940.6125789
Gross profit: 259939209.72644374
Operating income: 123488426.46714987
Net income: 159241290.62426934
Capital expenditures: 0
Depreciation & amortization: 23541033.434650455
Net tangible assets: 2341312836.10007
Owner earnings: 182782324.0589198
Return on net tangible assets (%): 7.806830477356487
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 61.60870579997666
P/E ratio: 26.55001963104672
Shares outstanding: 274497530
Book value: 2489652794.014496
P/B ratio: 6.7926891690471605
Market cap (USD): 16911437568.590267
Debt to equity: 0.021511995638717932
Current ratio: 1.6302200301000054
Quick ratio: 1.2636399439258472
Effective tax rate (%): 18.393083946416162
Interest coverage ratio: 67.97425997425998
COGS to revenue (%): 56.828039872786086
Buyback yield (%): 0
Retained earnings: 2401458966.5653496
Inventory turnover: 1.871693045563549
Receivables turnover: 9.370460665162652
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.611013404118885
Rule of 40 score: 0
Financial ratios for EICHERMOT.NS — quarterly report dated 2025-06-30
Total revenue: 578705827.28762
Gross profit: 249590451.67329746
Operating income: 117566112.80131057
Net income: 141027381.23098525
Capital expenditures: 0
Depreciation & amortization: 23175754.73905921
Owner earnings: 164203135.97004446
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 65.34156330446993
P/E ratio: 59.733496746746134
Shares outstanding: 274497530
Market cap (USD): 17936097733.415634
Effective tax rate (%): 24.34227459054984
Interest coverage ratio: 67.43087248322148
COGS to revenue (%): 56.87092821526928
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.885739564492302
Rule of 40 score: -3.885739564492302
Financial ratios for EICHERMOT.NS — quarterly report dated 2025-09-30
Total revenue: 684463359.6392334
Gross profit: 292721533.2581736
Operating income: 147952649.37993234
Net income: 154391206.313416
Capital expenditures: 0
Depreciation & amortization: 22498308.906426154
Net tangible assets: 2325985343.8556933
Owner earnings: 176889515.21984217
Return on net tangible assets (%): 7.604928194715941
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 78.97970687711387
P/E ratio: 47.68341236797891
Shares outstanding: 274497530
Book value: 2489974069.898535
P/B ratio: 8.706811335900865
Market cap (USD): 21679734457.89177
Debt to equity: 0.02018376288764818
Current ratio: 1.5869756317761006
Quick ratio: 1.223727142415915
Effective tax rate (%): 23.021793019713215
Interest coverage ratio: 68.4937369519833
COGS to revenue (%): 57.23342540753955
Buyback yield (%): 0
Inventory turnover: 1.8938960380659615
Receivables turnover: 14.757748122219791
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.492508978469669
Revenue growth (%): 18.27483452988479
Rule of 40 score: 18.27483452988479
Financial ratios for EICHERMOT.NS — quarterly report dated 2025-12-31
Total revenue: 668355798.1508299
Gross profit: 289811741.11618584
Operating income: 149896401.91600758
Net income: 158249972.15105268
Capital expenditures: 0
Depreciation & amortization: 23515651.108388104
Owner earnings: 181765623.25944078
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 81.4581708811407
P/E ratio: 36.48181978724434
Shares outstanding: 274497530
Market cap (USD): 22360066705.191048
Effective tax rate (%): 20.77793888021414
Interest coverage ratio: 77.9166184134337
COGS to revenue (%): 56.63810474630115
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.353312454430491
Rule of 40 score: -2.353312454430491
Financial ratios for ELR.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.22834645669291337
Shares outstanding: 205991426
Market cap (USD): 47037412.23622047
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELR.TO — annual report dated 2022-12-31
Total revenue: 39619852.94117647
Gross profit: 5617647.058823529
Operating income: -3487499.9999999995
Net income: -583823.5294117647
Capital expenditures: 591176.4705882353
Operating cash flow: -3982352.9411764704
Depreciation & amortization: 3165441.176470588
Net tangible assets: 54142647.058823526
Owner earnings: 1990441.176470588
Buffett classification: The Gruesome
Stock price: 0.1102941176470588
Shares outstanding: 205991426
Book value: 53821323.52941176
P/B ratio: 0.422130878314685
Market cap (USD): 22719642.573529407
Debt to equity: 0.06982526606281678
Current ratio: 0.473434059041619
Quick ratio: 0.3493574554679006
Interest coverage ratio: -0.9296354370834966
COGS to revenue (%): 85.82113096895125
SG&A to revenue (%): 5.298517157545051
Free cash flow (dilution-adjusted): -6255882.352941176
Buyback yield (%): 0
Retained earnings: -625395588.2352941
Inventory turnover: 5.194675353853067
Receivables turnover: 2.3803065777267305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.823990962560935
FCF margin (%): -15.789766716775237
Rule of 40 score: -15.789766716775237
Financial ratios for ELR.TO — annual report dated 2023-12-31
Total revenue: 81018181.81818181
Gross profit: 23912121.21212121
Operating income: 14046212.121212121
Net income: 10423484.848484848
Capital expenditures: 1995454.5454545454
Operating cash flow: 14309090.909090908
Depreciation & amortization: 4720454.545454545
Net tangible assets: 66729545.45454545
Owner earnings: 13148484.848484848
Return on net tangible assets (%): 19.704142683605237
Capex to operating income (%): 14.206353486866943
Buffett classification: The Great
Stock price: 0.14393939393939392
P/E ratio: 2.844565080311069
Shares outstanding: 205991426
Book value: 66412878.78787879
P/B ratio: 0.4464537836080533
Market cap (USD): 29650281.015151512
Debt to equity: 0.01682541493184281
Current ratio: 0.7754345307068367
Quick ratio: 0.7098203939745077
Effective tax rate (%): 0.31177494199535966
Interest coverage ratio: 3.5215574548907886
COGS to revenue (%): 70.48548773189707
SG&A to revenue (%): 2.721985338120886
Free cash flow (dilution-adjusted): 12217424.242424242
Buyback yield (%): 0
Retained earnings: -633920454.5454545
Inventory turnover: 16.6401766004415
Receivables turnover: 3.8667968326282676
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.212580398997055
FCF margin (%): 15.07985487731897
Revenue growth (%): 104.48885042170495
Rule of 40 score: 119.56870529902392
Financial ratios for ELR.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1259259259259259
Shares outstanding: 205991426
Market cap (USD): 25939661.05185185
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELR.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 1406293.7062937063
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 205991426
Market cap (USD): 20166992.755244758
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELR.TO — annual report dated 2024-12-31
Total revenue: 43711188.81118881
Gross profit: 575524.4755244756
Operating income: -8893006.993006993
Net income: -8934965.034965035
Capital expenditures: 11207692.307692308
Operating cash flow: -3100699.300699301
Depreciation & amortization: 3298601.398601399
Net tangible assets: 51941258.74125874
Owner earnings: -16844055.944055945
Return on net tangible assets (%): -32.42904841402338
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 205991426
Book value: 51651748.25174825
P/B ratio: 0.3904416295253311
Market cap (USD): 20166992.755244758
Debt to equity: 0.034754000704015596
Current ratio: 0.508662156845325
Quick ratio: 0.3859324034470943
Interest coverage ratio: -29.92235294117647
COGS to revenue (%): 98.68334746508393
SG&A to revenue (%): 4.8378581598860935
Free cash flow (dilution-adjusted): -14581818.181818182
Buyback yield (%): 0
Retained earnings: -593583216.7832168
Inventory turnover: 6.378903826266805
Receivables turnover: 2.291144344256286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.12093553907587
FCF margin (%): -33.359463740061116
Revenue growth (%): -46.04767987846982
Rule of 40 score: -79.40714361853094
Financial ratios for ELR.TO — quarterly report dated 2025-03-31
Total revenue: 10352447.552447554
Gross profit: -3274125.874125874
Operating income: -5663636.363636364
Net income: -4820279.720279721
Capital expenditures: 1584615.3846153847
Operating cash flow: 1393006.993006993
Depreciation & amortization: 531468.5314685315
Net tangible assets: 48557342.65734266
Owner earnings: -5873426.5734265745
Return on net tangible assets (%): -12.095856675835652
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 205991426
Book value: 48259440.55944057
P/B ratio: 0.4178869983046181
Market cap (USD): 20166992.755244758
Debt to equity: 0.041645534769819297
Current ratio: 0.4431596741248562
Quick ratio: 0.35199445918343386
Interest coverage ratio: -47.641176470588235
COGS to revenue (%): 131.6265874088084
SG&A to revenue (%): 3.8300459335314776
Free cash flow (dilution-adjusted): -191608.39160839163
Buyback yield (%): 0
Retained earnings: -598392307.6923077
Inventory turnover: 2.5091424156579962
Receivables turnover: 0.5849533744270586
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.901724300386316
FCF margin (%): -1.8508511213185623
Rule of 40 score: -1.8508511213185623
Financial ratios for ELR.TO — quarterly report dated 2025-06-30
Total revenue: 7833576.642335766
Gross profit: 264963.503649635
Operating income: -2205109.4890510947
Net income: -1304379.5620437956
Capital expenditures: 518248.1751824817
Operating cash flow: -2130656.9343065694
Depreciation & amortization: 116058.39416058394
Net tangible assets: 48659854.01459853
Owner earnings: -1706569.3430656935
Return on net tangible assets (%): -3.507140285611425
Buffett classification: The Gruesome
Stock price: 0.20437956204379562
Shares outstanding: 205991426
Book value: 48335036.49635035
P/B ratio: 0.8710128404234437
Market cap (USD): 42100437.43065693
Debt to equity: 0.06395445415968228
Current ratio: 0.4585169958464017
Quick ratio: 0.33723616173603466
Interest coverage ratio: -9.126888217522659
COGS to revenue (%): 96.61759224748415
SG&A to revenue (%): 4.6216921356690275
Free cash flow (dilution-adjusted): -2648905.1094890507
Buyback yield (%): 0
Retained earnings: -625873722.6277372
Inventory turnover: 0.9059059933601258
Receivables turnover: 0.3649595320682854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.0403905309616155
FCF margin (%): -33.814759597465525
Revenue growth (%): -24.331163208996596
Rule of 40 score: -58.145922806462124
Financial ratios for ELR.TO — quarterly report dated 2025-09-30
Total revenue: 9889208.633093527
Gross profit: -176258.9928057554
Operating income: -2457553.9568345323
Net income: -1584892.0863309354
Capital expenditures: 156834.53237410073
Operating cash flow: -1809352.5179856117
Depreciation & amortization: 97122.30215827339
Net tangible assets: 49658992.8057554
Owner earnings: -1644604.3165467628
Return on net tangible assets (%): -3.311795555298004
Buffett classification: The Gruesome
Stock price: 0.2302158273381295
Shares outstanding: 205991426
Book value: 49326618.70503597
P/B ratio: 0.961397472726212
Market cap (USD): 47422486.56115108
Debt to equity: 0.0805670614316551
Current ratio: 0.4451644763363702
Quick ratio: 0.3217769894380392
Interest coverage ratio: -8.58291457286432
COGS to revenue (%): 101.78233667976137
SG&A to revenue (%): 3.804743198021242
Free cash flow (dilution-adjusted): -1966187.0503597124
Buyback yield (%): 0
Retained earnings: -618388489.2086332
Inventory turnover: 1.1427754635301806
Receivables turnover: 0.43196530702030045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.59207678554625
FCF margin (%): -19.88214753382802
Revenue growth (%): 26.24129544668405
Rule of 40 score: 6.359147912856027
Financial ratios for ELR.TO — quarterly report dated 2025-12-31
Total revenue: 16280291.970802918
Gross profit: 4591240.875912408
Operating income: 2173722.627737226
Net income: -5466423.357664233
Capital expenditures: 537956.204379562
Operating cash flow: -1532846.715328467
Depreciation & amortization: 330656.93430656934
Net tangible assets: 46892700.729927
Owner earnings: -5673722.627737226
Return on net tangible assets (%): -12.099372694301325
Capex to operating income (%): 24.748153122901282
Buffett classification: The Great
Stock price: 0.3795620437956204
Shares outstanding: 205991426
Book value: 46540145.98540147
P/B ratio: 1.6799802622333748
Market cap (USD): 78186526.6569343
Debt to equity: 0.15732434127979922
Current ratio: 0.4696523715488655
Quick ratio: 0.362299265993517
Interest coverage ratio: 14.317307692307692
COGS to revenue (%): 71.79878048780488
SG&A to revenue (%): 1.6319942611190816
Free cash flow (dilution-adjusted): -2070802.9197080291
Buyback yield (%): 0
Retained earnings: -632808029.1970803
Inventory turnover: 1.3895010845986986
Receivables turnover: 0.5760628131618369
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.225971703869785
FCF margin (%): -12.719691535150645
Revenue growth (%): 64.62684300462719
Rule of 40 score: 51.907151469476545
Financial ratios for ELR.TO — annual report dated 2025-12-31
Total revenue: 44953284.67153284
Gross profit: 1259854.01459854
Operating income: -8436496.350364963
Net income: -13410218.978102189
Capital expenditures: 2869343.0656934306
Operating cash flow: -4045255.4744525542
Depreciation & amortization: 1100000
Net tangible assets: 46892700.729927
Owner earnings: -15179562.04379562
Return on net tangible assets (%): -32.37084195943527
Buffett classification: The Gruesome
Stock price: 0.3795620437956204
Shares outstanding: 205991426
Book value: 46540145.98540147
P/B ratio: 1.6799802622333748
Market cap (USD): 78186526.6569343
Debt to equity: 0.15732434127979922
Current ratio: 0.4696523715488655
Quick ratio: 0.362299265993517
Interest coverage ratio: -10.440831074977416
COGS to revenue (%): 97.1974149969149
SG&A to revenue (%): 3.16630403013672
Free cash flow (dilution-adjusted): -6914598.540145985
Buyback yield (%): 0
Retained earnings: -632808029.1970803
Inventory turnover: 5.193926247288504
Receivables turnover: 1.5906296812851903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.401538265052714
FCF margin (%): -15.381742603838536
Revenue growth (%): 2.841597069595346
Rule of 40 score: -12.54014553424319
Financial ratios for FLXS — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.91
Shares outstanding: 4075661
Market cap (USD): 146356986.51
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLXS — annual report dated 2022-06-30
Total revenue: 544282000
Gross profit: 72680000
Operating income: 5947000
Net income: 1853000
Capital expenditures: 1937000
Operating cash flow: 7993000
Depreciation & amortization: 5171000
Net tangible assets: 131560000
Owner earnings: 5087000
Return on net tangible assets (%): 3.86667680145941
Capex to operating income (%): 32.57104422397848
Buffett classification: The Good
Stock price: 16.42
P/E ratio: 36.115679233675124
Shares outstanding: 4075661
Book value: 131560000
P/B ratio: 0.5086831378838553
Market cap (USD): 66922353.620000005
Debt to equity: 0.5935846761933719
Current ratio: 2.9409998916861375
Quick ratio: 0.7559688675011992
Effective tax rate (%): 68.60918177198036
Interest coverage ratio: 7.122155688622755
COGS to revenue (%): 86.646628034732
SG&A to revenue (%): 12.260739837069755
Free cash flow (dilution-adjusted): 3120000
Buyback yield (%): 52.377117814823194
Retained earnings: 155275000
Inventory turnover: 3.3396736821233324
Receivables turnover: 13.240938062569942
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9135679081297705
FCF margin (%): 0.5732322582778779
Rule of 40 score: 0.5732322582778779
Financial ratios for FLXS — annual report dated 2023-06-30
Total revenue: 393692000
Gross profit: 70947000
Operating income: 7754000
Net income: 14778000
Capital expenditures: 340000
Operating cash flow: 22989000
Depreciation & amortization: 4572000
Net tangible assets: 141621000
Owner earnings: 19010000
Return on net tangible assets (%): 13.423150521462212
Capex to operating income (%): 4.3848336342532885
Buffett classification: The Great
Stock price: 18.03
P/E ratio: 4.972538085667885
Shares outstanding: 4075661
Book value: 141621000
P/B ratio: 0.5188790351007266
Market cap (USD): 73484167.83
Debt to equity: 0.7091179980370143
Current ratio: 3.096669993648489
Quick ratio: 0.8813356319753198
Effective tax rate (%): -60.2993817116824
Interest coverage ratio: 5.7822520507084265
COGS to revenue (%): 81.97905977261412
SG&A to revenue (%): 15.963240299523484
Free cash flow (dilution-adjusted): 15008000
Buyback yield (%): 5.035098184087309
Retained earnings: 166796000
Inventory turnover: 2.6438038598905598
Receivables turnover: 10.314713896457766
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2933381469132916
FCF margin (%): 3.8121170864533696
Revenue growth (%): -27.667642876303095
Rule of 40 score: -23.855525789849725
Financial ratios for FLXS — annual report dated 2024-06-30
Total revenue: 412752000
Gross profit: 87244000
Operating income: 16800000
Net income: 10528000
Capital expenditures: 4179000
Operating cash flow: 31883000
Depreciation & amortization: 3997000
Net tangible assets: 150367000
Owner earnings: 10346000
Return on net tangible assets (%): 6.880499045668264
Capex to operating income (%): 24.875
Buffett classification: The Great
Stock price: 30.03
P/E ratio: 11.625389421542554
Shares outstanding: 4075661
Book value: 150367000
P/B ratio: 0.8139558535449932
Market cap (USD): 122392099.83
Debt to equity: 0.4682875896972075
Current ratio: 2.572277588319041
Quick ratio: 0.9734794556832103
Effective tax rate (%): 32.29581993569132
Interest coverage ratio: 10.838709677419354
COGS to revenue (%): 78.86285226964375
SG&A to revenue (%): 17.066907004690467
Free cash flow (dilution-adjusted): 22464000
Buyback yield (%): 1.3554796447681798
Retained earnings: 174118000
Inventory turnover: 3.370450521345662
Receivables turnover: 9.33025905330259
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.848413499271219
FCF margin (%): 5.442493313175951
Revenue growth (%): 4.841348058888674
Rule of 40 score: 10.283841372064625
Financial ratios for FLXS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 42.99
Shares outstanding: 4075661
Market cap (USD): 175212666.39000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLXS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.9
Shares outstanding: 4075661
Market cap (USD): 215602466.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLXS — quarterly report dated 2025-03-31
Total revenue: 113972000
Gross profit: 25336000
Operating income: 8266000
Net income: -3742000
Capital expenditures: 834000
Operating cash flow: 12262000
Depreciation & amortization: 924000
Net tangible assets: 158119000
Owner earnings: -3652000
Return on net tangible assets (%): -2.30965285639297
Capex to operating income (%): 10.08952334865715
Buffett classification: The Great
Stock price: 35.7
Shares outstanding: 4075661
Book value: 158119000
P/B ratio: 0.9201999614214611
Market cap (USD): 145501097.70000002
Debt to equity: 0.3867466907835238
Current ratio: 2.933803185523069
Quick ratio: 1.3047932401106708
COGS to revenue (%): 77.76997859123294
SG&A to revenue (%): 14.977362861053592
Free cash flow (dilution-adjusted): 10044000
Buyback yield (%): 0
Retained earnings: 180817000
Inventory turnover: 1.0171794489264279
Receivables turnover: 2.963775841893122
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.887430984696709
FCF margin (%): 8.81269083634577
Rule of 40 score: 8.81269083634577
Financial ratios for FLXS — quarterly report dated 2025-06-30
Total revenue: 114611000
Gross profit: 27436000
Operating income: 10272000
Net income: 10702000
Capital expenditures: 3997000
Operating cash flow: 15626000
Depreciation & amortization: 877000
Net tangible assets: 167862000
Owner earnings: 7582000
Return on net tangible assets (%): 4.5168054711608345
Capex to operating income (%): 38.91160436137071
Buffett classification: The Good
Stock price: 35.42
P/E ratio: 20.741366755747126
Shares outstanding: 4075661
Book value: 167862000
P/B ratio: 0.8599916158511158
Market cap (USD): 144359912.62
Debt to equity: 0.3536833827787111
Current ratio: 2.7795659044731833
Quick ratio: 1.342229174057471
Effective tax rate (%): 24.961435983732997
COGS to revenue (%): 76.06163457259775
SG&A to revenue (%): 14.975874916020276
Free cash flow (dilution-adjusted): 14152000
Buyback yield (%): 0
Retained earnings: 190435000
Inventory turnover: 0.9780108823694396
Receivables turnover: 3.253314031053961
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.659095032475779
FCF margin (%): 12.347854917939815
Revenue growth (%): 0.560664022742428
Rule of 40 score: 12.908518940682242
Financial ratios for FLXS — annual report dated 2025-06-30
Total revenue: 441073000
Gross profit: 97944000
Operating income: 31248000
Net income: 20154000
Capital expenditures: 11535000
Operating cash flow: 36979000
Depreciation & amortization: 3654000
Net tangible assets: 167862000
Owner earnings: 12273000
Return on net tangible assets (%): 7.311362905243593
Capex to operating income (%): 36.91436251920123
Buffett classification: The Good
Stock price: 35.42
P/E ratio: 7.1628417495286305
Shares outstanding: 4075661
Book value: 167862000
P/B ratio: 0.8599916158511158
Market cap (USD): 144359912.62
Debt to equity: 0.3536833827787111
Current ratio: 2.7795659044731833
Quick ratio: 1.342229174057471
Effective tax rate (%): 25.26144033227027
Interest coverage ratio: 446.4
COGS to revenue (%): 77.79415198844636
SG&A to revenue (%): 15.12130645040617
Free cash flow (dilution-adjusted): 29852000
Buyback yield (%): 0
Retained earnings: 190435000
Inventory turnover: 3.8495428282941604
Receivables turnover: 12.520168043373356
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.173228346456693
FCF margin (%): 6.768040664470506
Revenue growth (%): 6.8615052137845485
Rule of 40 score: 13.629545878255055
Financial ratios for FLXS — quarterly report dated 2025-09-30
Total revenue: 110439000
Gross profit: 25946000
Operating income: 8987000
Net income: 7327000
Capital expenditures: 1357000
Operating cash flow: 4114000
Depreciation & amortization: 836000
Net tangible assets: 172184000
Owner earnings: 6806000
Return on net tangible assets (%): 3.95274822283139
Capex to operating income (%): 15.099588294202738
Buffett classification: The Great
Stock price: 45.75
P/E ratio: 13.051129750822426
Shares outstanding: 4075661
Book value: 172184000
P/B ratio: 1.0829199620754542
Market cap (USD): 186461490.75
Debt to equity: 0.3357629047995168
Current ratio: 2.9974190681297643
Quick ratio: 1.5108706799302636
Effective tax rate (%): 21.87033482618895
COGS to revenue (%): 76.50648774436567
SG&A to revenue (%): 15.355988373672345
Free cash flow (dilution-adjusted): 1640000
Buyback yield (%): 0.606023257378682
Retained earnings: 196671000
Inventory turnover: 0.9714965736098974
Receivables turnover: 3.1336435604233466
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.030623228445338
FCF margin (%): 1.4849826601110114
Revenue growth (%): -3.6401392536493007
Rule of 40 score: -2.1551565935382895
Financial ratios for FLXS — quarterly report dated 2025-12-31
Total revenue: 118249000
Gross profit: 26824000
Operating income: 8997000
Net income: 6644000
Capital expenditures: 1742000
Operating cash flow: 1007000
Depreciation & amortization: 864000
Net tangible assets: 178866000
Owner earnings: 5766000
Return on net tangible assets (%): 3.2236422796954143
Capex to operating income (%): 19.362009558741804
Buffett classification: The Great
Stock price: 39.17
P/E ratio: 7.627138759256606
Shares outstanding: 4075661
Book value: 178866000
P/B ratio: 0.8925320707680611
Market cap (USD): 159643641.37
Debt to equity: 0.3123790994375678
Current ratio: 3.0110962097263467
Quick ratio: 1.4928952326212601
Effective tax rate (%): 28.941176470588236
COGS to revenue (%): 77.31566440308163
SG&A to revenue (%): 15.075814594626594
Free cash flow (dilution-adjusted): -1879000
Buyback yield (%): 0
Retained earnings: 202221000
Inventory turnover: 0.9614474555951668
Receivables turnover: 2.8267594186268883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9536825452627875
FCF margin (%): -1.589019780294125
Revenue growth (%): 7.0717771801628055
Rule of 40 score: 5.482757399868681
Financial ratios for G50.AX — annual report dated 2022-06-30
Operating income: -1417465.5172413792
Net income: -1406255.8620689656
Capital expenditures: 7726.206896551725
Depreciation & amortization: 5932.413793103448
Net tangible assets: 7500705.517241379
Owner earnings: -1408049.6551724137
Return on net tangible assets (%): -18.77222951808763
Buffett classification: The Gruesome
Stock price: 0.10344827586206896
Shares outstanding: 205093842
Book value: 7500705.51724138
P/B ratio: 2.8286144944710023
Market cap (USD): 21216604.344827585
Debt to equity: 0
Current ratio: 26.378481042375864
Quick ratio: 26.378481042375864
Interest coverage ratio: -612.2505212987786
Free cash flow (dilution-adjusted): -3177175.1724137934
Buyback yield (%): 1.2705793477699834
Retained earnings: -1789273.7931034483
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.897762536912616
Rule of 40 score: 0
Financial ratios for G50.AX — annual report dated 2023-06-30
Operating income: -1614144.370860927
Net income: -1602094.0397350993
Capital expenditures: 1523.1788079470198
Depreciation & amortization: 27842.384105960264
Net tangible assets: 6265009.9337748345
Owner earnings: -1575774.834437086
Return on net tangible assets (%): -25.15199259209538
Buffett classification: The Gruesome
Stock price: 0.11258278145695365
Shares outstanding: 205093842
Book value: 6265009.9337748345
P/B ratio: 3.685554442232245
Market cap (USD): 23090035.192052983
Debt to equity: 0.04732708150439236
Current ratio: 2.3255344502543305
Quick ratio: 2.3255344502543305
Interest coverage ratio: -277.19299442738543
Free cash flow (dilution-adjusted): -3186933.7748344373
Buyback yield (%): 0.07712394923502153
Retained earnings: -3320270.1986754965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.75944857825757
Rule of 40 score: 0
Financial ratios for G6M.AX — annual report dated 2021-06-30
Operating income: -3616068.4210526315
Net income: -3665667.669172932
Capital expenditures: 177930.07518796992
Depreciation & amortization: 174439.0977443609
Net tangible assets: 5000466.917293233
Owner earnings: -3669158.646616541
Return on net tangible assets (%): -73.37632079771197
Buffett classification: The Gruesome
Stock price: 0.17293233082706766
Shares outstanding: 247652182
Book value: 5000466.917293233
P/B ratio: 8.56461402025465
Market cap (USD): 42827069.06766917
Debt to equity: 0.01499228417917665
Current ratio: 5.245411706909828
Quick ratio: 5.245411706909828
Interest coverage ratio: -16.603905362623554
Free cash flow (dilution-adjusted): -1996485.714285714
Buyback yield (%): 0.6438307374029991
Retained earnings: -50783541.35338346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -72.13254386112264
Rule of 40 score: 0
Financial ratios for G6M.AX — annual report dated 2022-06-30
Operating income: -7996995.172413793
Net income: -9412454.48275862
Capital expenditures: 23541922.75862069
Depreciation & amortization: 287406.8965517242
Net tangible assets: 16464808.27586207
Owner earnings: -32666970.344827585
Return on net tangible assets (%): -198.40480251882676
Buffett classification: The Gruesome
Stock price: 0.13793103448275862
Shares outstanding: 247652182
Book value: 16599206.896551728
P/B ratio: 2.0578646840210473
Market cap (USD): 34158921.655172415
Debt to equity: 0.5251609029928724
Current ratio: 0.8992412445883823
Quick ratio: 0.8992412445883823
Interest coverage ratio: -699.9241262751252
Free cash flow (dilution-adjusted): -26384830.34482759
Buyback yield (%): 2.0978595698381532
Retained earnings: -55993220
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.18486507262169
Rule of 40 score: 0
Financial ratios for G6M.AX — annual report dated 2023-06-30
Operating income: -15367841.721854305
Net income: -14480639.735099338
Capital expenditures: 37251326.49006622
Depreciation & amortization: 2265662.251655629
Net tangible assets: 46998896.68874172
Owner earnings: -49466303.97350993
Return on net tangible assets (%): -105.24992597402667
Buffett classification: The Gruesome
Stock price: 0.08609271523178808
Shares outstanding: 247652182
Book value: 46998896.688741714
P/B ratio: 0.4536499850764427
Market cap (USD): 21321048.78145695
Debt to equity: 0.6906127034065646
Current ratio: 0.5277445264127715
Quick ratio: 0.4122101655266473
Interest coverage ratio: -42.68577940305426
Free cash flow (dilution-adjusted): -49148641.72185431
Buyback yield (%): 6.686570789648226
Retained earnings: -68248963.57615894
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.974783272985906
Rule of 40 score: 0
Financial ratios for GPTHEALTH.NS — annual report dated 2024-03-31
Total revenue: 47796330.49526322
Gross profit: 30137246.672262862
Operating income: 8704245.11332294
Net income: 5728384.698405084
Capital expenditures: 2304365.0317783905
Operating cash flow: 8250425.710516849
Depreciation & amortization: 2156361.6740616383
Net tangible assets: 26099460.366950475
Owner earnings: 5580381.340688332
Return on net tangible assets (%): 21.381213489588934
Capex to operating income (%): 26.47403653938089
Buffett classification: The Good
Stock price: 2.038747600767754
P/E ratio: 29.203533339730114
Shares outstanding: 82054823
Book value: 26201019.30687133
P/B ratio: 6.384830741252897
Market cap (USD): 167289073.5226727
Debt to equity: 0.1397920182268961
Current ratio: 1.0381941791081504
Quick ratio: 0.9325718415554843
Effective tax rate (%): 29.796277081980033
Interest coverage ratio: 11.176161734363932
COGS to revenue (%): 36.946526312831566
SG&A to revenue (%): 1.827240941196306
Free cash flow (dilution-adjusted): 5927917.016428828
Buyback yield (%): 0
Retained earnings: 7121441.419834512
Inventory turnover: 18.057744423598084
Receivables turnover: 16.412471998945843
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.05251082328527
FCF margin (%): 12.40245214434674
Revenue growth (%): 9.514135207644578
Rule of 40 score: 21.916587351991318
Financial ratios for GPTHEALTH.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 27439667.940754898
Buffett classification: The Gruesome
Stock price: 2.1209985666507407
Shares outstanding: 82054823
Book value: 27588939.32154802
P/B ratio: 6.3082585358346766
Market cap (USD): 174038161.96978024
Debt to equity: 0.12075440329802498
Current ratio: 1.0951078766263123
Quick ratio: 0.9521509393680615
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPTHEALTH.NS — quarterly report dated 2025-03-31
Total revenue: 11854360.533083936
Gross profit: 7410942.249240121
Operating income: 1849333.6450783259
Net income: 1506897.3579611876
Capital expenditures: 0
Depreciation & amortization: 569429.5066635492
Net tangible assets: 28859492.635024548
Owner earnings: 2076326.8646247368
Return on net tangible assets (%): 7.194606263122099
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.687128019605555
P/E ratio: 22.96722306527529
Shares outstanding: 82054823
Book value: 28974818.79822305
P/B ratio: 4.77783802518773
Market cap (USD): 138436991.02707434
Debt to equity: 0.1424140187677577
Current ratio: 1.061593519675876
Quick ratio: 0.9427274147666047
Effective tax rate (%): 21.253108028028763
Interest coverage ratio: 15.551710578057412
COGS to revenue (%): 37.48340765782202
Buyback yield (%): 0
Retained earnings: 10374795.417348608
Inventory turnover: 4.306968838526912
Receivables turnover: 5.14758109548708
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.1027998433599935
Rule of 40 score: 0
Financial ratios for GPTHEALTH.NS — annual report dated 2025-03-31
Total revenue: 47412882.86181903
Gross profit: 30233434.650455926
Operating income: 8018926.8178629875
Net income: 5836064.9988309555
Capital expenditures: 5779401.449614215
Operating cash flow: 7878898.7608136535
Depreciation & amortization: 2224690.2034136076
Net tangible assets: 28859492.635024548
Owner earnings: 2281353.7526303483
Return on net tangible assets (%): 7.905037630015868
Capex to operating income (%): 72.0720064029017
Buffett classification: The Good
Stock price: 1.687128019605555
P/E ratio: 23.72094742858505
Shares outstanding: 82054823
Book value: 28974818.79822305
P/B ratio: 4.77783802518773
Market cap (USD): 138436991.02707434
Debt to equity: 0.1424140187677577
Current ratio: 1.061593519675876
Quick ratio: 0.9427274147666047
Effective tax rate (%): 28.01028471885743
Interest coverage ratio: 27.117572642814785
COGS to revenue (%): 36.23371365422179
SG&A to revenue (%): 2.9873279519333042
Free cash flow (dilution-adjusted): 2042377.8349310262
Buyback yield (%): 0
Retained earnings: 10374795.417348608
Inventory turnover: 16.651898016997166
Receivables turnover: 20.588344586019595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.12633648828329
FCF margin (%): 4.307643221955875
Revenue growth (%): -0.8022532890515329
Rule of 40 score: 3.505389932904342
Financial ratios for GPTHEALTH.NS — quarterly report dated 2025-06-30
Total revenue: 12533185.11584367
Gross profit: 7724713.316171309
Operating income: 1308612.2162415166
Net income: 898876.6674467588
Capital expenditures: 0
Depreciation & amortization: 723332.5532412825
Owner earnings: 1622209.2206880413
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6692019658319683
P/E ratio: 38.09367759167773
Shares outstanding: 82054823
Market cap (USD): 136966071.85759422
Effective tax rate (%): 30.879283040598903
Interest coverage ratio: 6.84921607055365
COGS to revenue (%): 38.36592019688428
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.726370316350895
Rule of 40 score: 5.726370316350895
Financial ratios for GPTHEALTH.NS — quarterly report dated 2025-09-30
Total revenue: 13405636.97857948
Gross profit: 8616065.388951521
Operating income: 1791984.2164599774
Net income: 1195535.5129650508
Capital expenditures: 0
Depreciation & amortization: 772006.7643742954
Net tangible assets: 28528489.289740697
Owner earnings: 1967542.2773393462
Return on net tangible assets (%): 6.8967629423227335
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6471251409244643
P/E ratio: 37.52928218396556
Shares outstanding: 82054823
Book value: 28613833.145434044
P/B ratio: 4.723399385551174
Market cap (USD): 135154561.89740697
Debt to equity: 0.38278132753254773
Current ratio: 1.0318985028317624
Quick ratio: 0.8871120272869271
Effective tax rate (%): 29.629580474338724
Interest coverage ratio: 7.346166289226788
COGS to revenue (%): 35.72804184747872
Buyback yield (%): 0
Inventory turnover: 3.464251349544172
Receivables turnover: 4.232520226810802
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.196388522283769
Revenue growth (%): 6.961134417722041
Rule of 40 score: 6.961134417722041
Financial ratios for GPTHEALTH.NS — quarterly report dated 2025-12-31
Total revenue: 13385162.080873344
Gross profit: 8376495.488470536
Operating income: 1514782.2212320375
Net income: 1043589.172329286
Capital expenditures: 0
Depreciation & amortization: 792012.9219115517
Owner earnings: 1835602.0942408377
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.5634399019717056
P/E ratio: 27.619070386150412
Shares outstanding: 82054823
Market cap (USD): 128287784.42742565
Effective tax rate (%): 26.567484734709236
Interest coverage ratio: 6.011316917908139
COGS to revenue (%): 37.41954383622978
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.1527334936702554
Rule of 40 score: -0.1527334936702554
Financial ratios for IKIO.NS — annual report dated 2024-03-31
Total revenue: 52518647.31982252
Gross profit: 21233241.395850822
Operating income: 9817604.029260103
Net income: 7263580.765079746
Capital expenditures: 9748291.162009833
Operating cash flow: -623815.8052524284
Depreciation & amortization: 1438901.5469480753
Net tangible assets: 66219930.44729584
Owner earnings: -1045808.8499820121
Return on net tangible assets (%): -1.5792962072262624
Capex to operating income (%): 99.29399406368712
Buffett classification: The Gruesome
Stock price: 3.351007677543186
P/E ratio: 35.6529693483867
Shares outstanding: 77280701
Book value: 66291641.68365511
P/B ratio: 3.90649885565846
Market cap (USD): 258968222.3769194
Debt to equity: 0.12722003740914534
Current ratio: 5.744661142127531
Quick ratio: 4.052712615477055
Effective tax rate (%): 28.326825227783697
Interest coverage ratio: 18.66598267213862
COGS to revenue (%): 59.57009085449808
R&D to revenue (%): 0.3637376613472222
SG&A to revenue (%): 2.236313029023662
Free cash flow (dilution-adjusted): -10661230.36335292
Buyback yield (%): 0
Retained earnings: 14612663.38889555
Inventory turnover: 1.9301805967609478
Receivables turnover: 4.520618503494049
Capitalized R&D asset: 299787.25393387943
ROCI (R&D-adjusted, %): 14.189176545731828
Rosenberg metric: 50.05540219843676
FCF margin (%): -20.299895194233173
Revenue growth (%): 20.18399077271831
Rule of 40 score: -0.11590442151486258
Financial ratios for IKIO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 65560081.223124705
Buffett classification: The Gruesome
Stock price: 3.4651218346870523
Shares outstanding: 77280701
Book value: 65754538.93932155
P/B ratio: 4.072525619594657
Market cap (USD): 267787044.43502152
Debt to equity: 0.10703782218613363
Current ratio: 4.186770235503661
Quick ratio: 2.826993865030675
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IKIO.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8447371488518476
Shares outstanding: 77280701
Market cap (USD): 219843281.02401212
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IKIO.NS — annual report dated 2025-03-31
Total revenue: 56801379.47159223
Gross profit: 20925298.106149167
Operating income: 4237315.875613748
Net income: 3789922.8431143323
Capital expenditures: 11006195.931727845
Operating cash flow: 4099485.6207622164
Depreciation & amortization: 2837502.9226093055
Net tangible assets: 64917114.80009352
Owner earnings: -4378770.166004207
Return on net tangible assets (%): -6.745170637185957
Capex to operating income (%): 259.74452353363125
Buffett classification: The Gruesome
Stock price: 2.7555140623176566
P/E ratio: 56.18796665957405
Shares outstanding: 77280701
Book value: 65703998.12953004
P/B ratio: 3.2410213139763058
Market cap (USD): 212948058.35126618
Debt to equity: 0.09383273550260483
Current ratio: 4.5505778115609825
Quick ratio: 2.90196800361058
Effective tax rate (%): 23.628354024829793
Interest coverage ratio: 11.087794432548181
COGS to revenue (%): 63.16058113233953
R&D to revenue (%): 0.34946972394361553
SG&A to revenue (%): 2.491361017866588
Free cash flow (dilution-adjusted): -7110825.344867897
Buyback yield (%): 0
Retained earnings: 16955576.33855506
Inventory turnover: 2.2108524004380152
Receivables turnover: 4.291042205756375
Capitalized R&D asset: 364156.3972995367
ROCI (R&D-adjusted, %): 6.140919584937607
Rosenberg metric: -1.6120144964357221
FCF margin (%): -12.518754669372415
Revenue growth (%): 8.154688611245415
Rule of 40 score: -4.364066058126999
Financial ratios for IKIO.NS — quarterly report dated 2025-03-31
Total revenue: 13126841.243862519
Gross profit: 5885784.42833762
Operating income: 12274.959083469721
Net income: -78325.92938975917
Capital expenditures: 0
Depreciation & amortization: 711012.3918634556
Net tangible assets: 64917114.80009352
Owner earnings: 632686.4624736964
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.7555140623176566
Shares outstanding: 77280701
Book value: 65703998.12953004
P/B ratio: 3.2410213139763058
Market cap (USD): 212948058.35126618
Debt to equity: 0.09383273550260483
Current ratio: 4.5505778115609825
Quick ratio: 2.90196800361058
Effective tax rate (%): 180.6257521058965
Interest coverage ratio: 0.06202008269344359
COGS to revenue (%): 55.16221824432036
Buyback yield (%): 0
Retained earnings: 16955576.33855506
Inventory turnover: 0.4462278831191286
Receivables turnover: 0.9916630604693062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.017754871175727566
Rule of 40 score: 0
Financial ratios for IKIO.NS — quarterly report dated 2025-06-30
Total revenue: 14057687.807161245
Gross profit: 5147203.36999766
Operating income: 497542.7100397847
Net income: 278258.83454247605
Capital expenditures: 0
Depreciation & amortization: 824128.2471331618
Owner earnings: 1102387.0816756377
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.4816288322022
P/E ratio: 959.2318764532857
Shares outstanding: 77280701
Market cap (USD): 191782015.7743974
Effective tax rate (%): 43.71597633136094
Interest coverage ratio: 2.049156626506024
COGS to revenue (%): 63.38513530386143
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.091169505336599
Rule of 40 score: 7.091169505336599
Financial ratios for IKIO.NS — quarterly report dated 2025-09-30
Total revenue: 18513641.488162346
Gross profit: 6473393.4611048475
Operating income: 1241037.2040586246
Net income: 1227846.674182638
Capital expenditures: 0
Depreciation & amortization: 831792.559188275
Net tangible assets: 64217812.85231116
Owner earnings: 2059639.2333709132
Return on net tangible assets (%): 3.2072709142363576
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.3697857948139793
P/E ratio: 128.2681935599046
Shares outstanding: 77280701
Book value: 65238218.71476889
P/B ratio: 2.807230348268335
Market cap (USD): 183138707.44306648
Debt to equity: 0.10202484001914758
Current ratio: 3.45504147215562
Quick ratio: 2.2923977599105316
Effective tax rate (%): 19.158254156769598
Interest coverage ratio: 5.921463152232383
COGS to revenue (%): 65.03446679982461
Buyback yield (%): 0
Inventory turnover: 0.7782449645844871
Receivables turnover: 1.2601078891028938
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8049511541652594
Revenue growth (%): 31.697628672128825
Rule of 40 score: 31.697628672128825
Financial ratios for IKIO.NS — quarterly report dated 2025-12-31
Total revenue: 16217890.16375181
Gross profit: 7162415.060710706
Operating income: 1544836.8051687647
Net income: 1199064.275370391
Capital expenditures: 0
Depreciation & amortization: 892837.2507519217
Owner earnings: 2091901.5261223128
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0245070736326167
P/E ratio: 59.56019256702758
Shares outstanding: 77280701
Market cap (USD): 156455325.82978722
Effective tax rate (%): 27.181707482072788
Interest coverage ratio: 6.778103616813294
COGS to revenue (%): 55.836332664780066
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.40032289638126
Rule of 40 score: -12.40032289638126
Financial ratios for INFI.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -3098184.558823529
Net income: -4933428.676470588
Capital expenditures: 0
Operating cash flow: -2468608.8235294116
Net tangible assets: 2450996.3235294116
Owner earnings: -4933428.676470588
Return on net tangible assets (%): -201.2825816632192
Buffett classification: The Gruesome
Stock price: 1.0588235294117645
Shares outstanding: 6128898
Book value: 2450996.3235294116
P/B ratio: 2.6476667261662796
Market cap (USD): 6489421.411764705
Debt to equity: 0
Current ratio: 0.6696845899542335
Quick ratio: 0.6696845899542335
Free cash flow (dilution-adjusted): -2838342.647058823
Buyback yield (%): 0
Retained earnings: -5851224.2647058815
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -126.40510836679562
Rule of 40 score: 0
Financial ratios for INFI.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -2224962.878787879
Net income: -2269015.1515151514
Capital expenditures: 0
Operating cash flow: -1509956.0606060605
Net tangible assets: 1947186.3636363635
Owner earnings: -2269015.1515151514
Return on net tangible assets (%): -116.52788833616181
Buffett classification: The Gruesome
Stock price: 0.24242424242424243
Shares outstanding: 6128898
Book value: 1947186.3636363638
P/B ratio: 0.763046353596448
Market cap (USD): 1485793.4545454546
Debt to equity: 0
Current ratio: 0.15998519315253149
Quick ratio: 0.15998519315253149
Free cash flow (dilution-adjusted): -1904463.6363636362
Buyback yield (%): 0
Retained earnings: -8297549.242424242
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -114.2655330963169
Rule of 40 score: 0
Financial ratios for INFI.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.17777777777777776
Shares outstanding: 6128898
Market cap (USD): 1089581.8666666665
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INFI.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -671402.097902098
Net income: -677644.055944056
Capital expenditures: 0
Operating cash flow: -330106.29370629374
Net tangible assets: 1579712.5874125874
Owner earnings: -677644.055944056
Return on net tangible assets (%): -42.896667491519445
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 6128898
Book value: 1579712.5874125874
P/B ratio: 0.32557385626933116
Market cap (USD): 514313.1188811189
Debt to equity: 0
Current ratio: 0.17314837071110512
Quick ratio: 0.17314837071110512
Interest coverage ratio: -1975.5246913580247
Free cash flow (dilution-adjusted): -479314.68531468534
Buyback yield (%): 0
Retained earnings: -8336920.27972028
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -42.501534978700654
Rule of 40 score: 0
Financial ratios for INFI.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -155241.95804195805
Net income: -155448.95104895104
Capital expenditures: 0
Operating cash flow: -37104.195804195806
Net tangible assets: 1579712.5874125874
Owner earnings: -155448.95104895104
Return on net tangible assets (%): -9.84033122781917
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 6128898
Book value: 1579712.5874125874
P/B ratio: 0.32557385626933116
Market cap (USD): 514313.1188811189
Debt to equity: 0
Current ratio: 0.17314837071110512
Quick ratio: 0.17314837071110512
Free cash flow (dilution-adjusted): -38323.77622377623
Buyback yield (%): 0
Retained earnings: -8336920.27972028
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.827228021030647
Rule of 40 score: 0
Financial ratios for INFI.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -123391.6083916084
Net income: -1433065.034965035
Capital expenditures: 0
Operating cash flow: -47421.67832167832
Net tangible assets: 189434.96503496505
Owner earnings: -1433065.034965035
Return on net tangible assets (%): -756.4944701209338
Buffett classification: The Gruesome
Stock price: 0.1118881118881119
Shares outstanding: 6128898
Book value: 189434.96503496508
P/B ratio: 3.6199802135168255
Market cap (USD): 685750.8251748253
Debt to equity: 0
Current ratio: 0.08853260930540441
Quick ratio: 0.08853260930540441
Interest coverage ratio: -479.483695652174
Free cash flow (dilution-adjusted): -87039.86013986015
Buyback yield (%): 0
Retained earnings: -9769985.314685315
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.1366596281913
Rule of 40 score: 0